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A B S T R A C T
Limb saving surgery is today’s tendency in treating the musculoskeletal tumours. Preserving the limb should not only
pursue a good oncological and functional result but also aim at good psychological outcome. Our aim was to treat a very
rare case of proximal femoral leiomyosarcoma with present solitary lung metastasis by conservative operative proce-
dures.
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Introduction
Soft tissue sarcomas (STS) are a heterogeneous group
of malignancies that arise most commonly in the extrem-
ities, with a frequency at this site of about 17 per mi-
llion1. Primary leiomyosarcoma of bone is a very rare
STS firstly reported by Carmody at al. in 19442. Clinical
follow-up suggests that primary osseous leiomyosarcoma
has an aggressive biologic behaviour with early meta-
stasis3–8. Radiological features of the tumors are rather
nonspecific, and most have an osteolytic lesion 5,9,10.
Early surgical intervention by radical or wide excision of-
fers the best chance of cure11,12. Adjuvant therapy is still
a question4–6,8,12–15. Today, tendency in treating the mus-
culoskeletal tumours is the preserving of the limb13. The
limb-saving surgery should not only pursue a good onco-
logical and functional result but also aim at good psycho-
logical outcome13. Our aim was to treat the very rare case
of proximal femoral leiomyosarcoma with present soli-
tary lung metastasis by conservative operative proce-
dures.
Case Report
A sixty years old woman came to our department with
gradually growing pain in the left hip. The symptoms
started four months ago and she could not recall any rel-
evant trauma to the area. Despite rest and pain-killers
the patient developed antalgic gait and night pain.
Physical examination revealed antalgic gait and with
pain limited passive or active motion in the left hip. Vas-
cular and neurological parameters were normal, with no
apparent peripheral, sensory, or motor loss except mus-
cular hypotrophy of the left leg.
The abnormal laboratory findings were a sedimenta-
tion rate of 76 mm in the first hour and the high levels of
liver enzymes. The erythrocytes, leukocytes, electrolytes,
and serum enzymes levels were within normal limits.
Radiograph of the left hip revealed a poorly defined
osteolytic mass, with suspected destruction of bone in
the upper cortex of femoral neck. The tumour had a
mainly metaphyseal location extending from linea inter-
trochanterica into the femoral head (Figure l). Magnetic
resonance revealed large intraosseous component with
heterogeneous signal intensity throughout the lesion.
The tumour occupied the femoral neck and extended into
the femoral metaphysis to the level of lesser trochanter
and femoral head without extension to surrounding soft
tissue (Figure 2). The scintigraphy (Tc-99m) revealed ac-
cumulation only in the left proximal femur. The CT scan
of chest, abdomen and pelvis was performed to exclude
primary or secondary malignancy. The uterus and GI
tract were evaluated and no malignancy was found14 but
in the chest a soft tissue, nodose formation was seen in
the left lung. Metastatic disease was suspected.
The patient was admitted to hospital and had an open
biopsy of the lesion. Histological examination, including
immunohistochemical studies, determinates the precise
diagnosis of primary leiomyosarcoma. Wide resection of
the tumour was planned. A proximal femoral resection
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with wide surgical margins was reconstructed with com-
posite allograft prosthesis reconstruction (Figure 3).
Two weeks after the orthopaedic procedure the pa-
tient was suitable for the thoracic surgery treatment for
the lung tumour. The right lung was treated operatively
by lobectomy of the affected lobus and confirmed to be a
leiomyosarcomametastasis by patohystological analysis.
Five cycles of adjuvant chemotherapy was performed
according to ifosfamide + epirubicin chemotherapy re-
gimen15. The patient has been checked up every three
months.
One year after the surgery the patient was very satis-
fied: She was self-sufficient and the hip was painless.
After two years the patient went to our hospital with
signs of gradually growing pain in the left hip and night
pain. After ultrasound and radiographic examination the
local recurrence was suspected and biopsy proven. The
patient died after two months for pulmonal metastases.
Discussion
In the 19th century, amputation was the primary
choice for surgical treatment in musculoskeletal oncolo-
gy13. After introduction of endoprothesis16, allografts17,18
and vascularised autogenous bone grafts19 in reconstruc-
tion after surgery for musculosceletal tumours, limb sav-
ing surgery was born.
The aim of limb-saving surgery should not only pur-
sue a good oncological and functional result but also a
good psychological outcome13. Limb-saving surgery was
firstly attempted on the thigh, upper part of the tibia,
and distal part of the femur16. There are general indica-
tions for the limb salvage: tumours of the extremities, ax-
ial skeleton, or both, in which optimum surgical margins
are attainable, soft-tissue extension is moderate, the
neurovascular bundles are not compromised, and meta-
stases are absent or responsive to curative treatment13.
In other cases the amputation is the procedure of choice.
Catton at al.20 agrees that despite the presence of metas-
tasis the limb salvage procedures are indicated.
All diagnostic procedures on our patient demonstrated
primary femoral and solitary metastatic lung intracom-
partmental tumours (Enneking's stage III a), without
other malignancy localizations. Despite the presence of
the solitary lung metastasis, we decided to treat the pa-
tient with limb salvage procedure and lung metasta-
sectomya, because of the localization of the tumour and
very demanding rehabilitation procedure after hip disar-
ticulation. Indeed, pulmonary metastasectomy in soft
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Fig. 1. Radiograph of the left hip with a poorly defined
osteolytic mass and suspected bone destruction in the upper
cortex of femoral neck.
Fig. 2. Magnetic resonance reveals large intraosseous component
with the tumour occupying the femoral neck and extending into
the femoral metaphysis to the level of lesser trochanter and
femoral head without extension to surrounding soft tissue.
Fig. 3. Proximal femoral resection with wide surgical
margins reconstructed with composite allograft
endoprosthesis reconstruction.
tissue sarcoma (STS) can lead to long-term survival and
good prognosis even in cases of repeated lung meta-
stasis21.
It is known that optimum surgical margins are 3 cm
of normal bone and 1 cm of normal soft tissues around a
malignant bone13. Furthermore, there are several ways
to reconstruct the operated limb. Reconstructions can be
achieved with allograft bone, mega-endoprosthetic re-
placements or composites, or with vascularised bone
grafts. Taking these facts into consideration and after ac-
curate preoperative planning, we performed a proximal
femoral resection three centimetres under the lesser
trochanter to obtain wide margin, and we reconstructed
the defect with composite allograft prosthesis. Naturally,
the quality of life in patients with bone tumours is af-
fected both by limb-saving methods and by amputa-
tion22,23.
However, 75% of amputees report difficulties in sex-
ual relationships, whereas hardly any limb-salvage pa-
tients do24. Also, the same percentage of amputated pa-
tients feel embarrassed to show their prostheses, and
they refrain from certain social activities24.
To assess the functional outcome we used the scoring
system of the Musculoskeletal Tumor Society (MTS)25.
The MTS is based on six categories: pain, function, emo-
tional acceptance, use of supports, ability to walk, and
gait. Each category was assigned a numerical value from
0 to 5 points, with 5 points indicating the best function.
The values for each category were added, and the func-
tional score was presented as a percentage of the maxi-
mum possible score (30 points). The Musculoskeletal Tu-
mor Society functional score at the time of the follow-up,
one year after the surgery was 4 for pain, 2 for function, 4
for emotional acceptance, 1 for use of supports, 3 for the
ability to walk and 2 for gait – MTS was 53%. Herein, it is
important to point out that the patient was personally
satisfied with operative procedure.
Local relapse of extremity STS after seemingly ade-
quate combined conservative therapy is uncommon, since
it is potentially devastating for the patient and is ex-
tremely frustrating for the physician, who has only lim-
ited data on which to determine the most appropriate
course of action. When local relapse occurs the tendency
has been to recommend limb amputation for local re-
lapse, partly because in this setting local recurrence may
not be amenable to a conservative resection, but also be-
cause of uncertainty about the efficacy of conservative
surgery when used alone20,26. The available data for the
most appropriate salvage therapy in cases of tumour re-
lapses is limited. In our case the patient was unsuitable
for reoperation and he died soon after the tumour relapse.
Our case suggests that primary leiomyosarcoma has
to be considered as differential diagnostic possibility in
case of bone tumours seen on routine initial plain radio-
graphs as lytic lesions. Despite moderate result in MTS
and short survivorship of our patient, we suggest that
limb salvage procedure is indicated in case of primary
bone leiomyosarcoma even in case of present metastasis
due to very good psychological outcome.
The results of limb salvage should be judged in terms
of oncology, function, and especially quality of life for so
aggressive and rare tumours like primary bone leiomy-
osarcoma.
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KIRURGIJA SPA[AVANJA EKSTREMITETA KOD LEIOMIOSARKOMA STUPNJA III A
PREMA ENNEKING-U
S A @ E T A K
Dana{nja je tendencija u lije~enju muskuloskeletnih tumora kirurgija spa{avanja ekstremiteta. ^uvanjem ekstre-
miteta posti`emo ne samo dobar onkolo{ki i funkcionalni rezultat ve} i dobar psiholo{ki rezultat. Cilj na{eg rada bio je
lije~enje vrlo rijetkog slu~aja uznapredovalog leiomiosarkoma sa prisutnom plu}nommetastazom, pomo}u konzervativne
kirur{ke procedure.
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